Familiarize Yourself With Vilobelimab for COVID-19

You’ll hear about the new COVID-19 treatment vilobelimab (Gohibic)...due to its emergency use authorization (EUA).

This med is a “complement inhibitor”...and it’s only authorized for treating COVID-19 in certain adults on mechanical ventilation or extracorporeal membrane oxygenation (ECMO).

Vilobelimab seems to reduce the risk of death when added to a steroid (dexamethasone, etc). But there are important limitations to the evidence supporting its use.